蛋白酶激活受体2在炎症性皮肤疾病:目前的证据和未来的前景
Mengjie Fan1, Xiaoyao Fan1, Yangfan Lai1
1Department of Dermatology, Huashan Hosptial, Fudan University, Shanghai, China.
Frontiers in immunology
|September 20, 2024
概括
蛋白酶激活受体-2 (PAR2) 显著影响皮肤炎症和屏障修复. 向PAR2为炎症性皮肤疾病 (如和牛皮) 提供了有希望的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- G蛋白结合受体 (GPCR) 信号传递
背景情况:
- 蛋白酶激活受体-2 (PAR2),一种皮肤表达的GPCR,由血清蛋白酶激活.
- PAR2在皮肤炎症反应,角质细胞分化和感觉传递中发挥着关键作用.
- PAR2的失调与各种炎症性皮肤疾病的发病有关.
研究的目的:
- 审查PAR2激活在炎症性皮肤疾病中的新兴作用.
- 突出PAR2调节器在皮肤疾病中的治疗潜力.
主要方法:
- 对研究皮肤中PAR2功能的文献综述.
- 分析PAR2在炎症途径和疾病发病过程中的参与.
- 评估目前和潜在的PAR2向疗法.
主要成果:
- PAR2的激活促进了Th2的炎症,并破坏了皮肤屏障的修复.
- PAR2 影响质细胞分化,并调解和疼痛信号.
- 在,粉红,牛皮和亚托皮性皮肤炎中,PAR2是关键因素.
结论:
- PAR2 是炎症性皮肤疾病发展的重要贡献者.
- 准PAR2为管理炎症性皮肤疾病提供了一个有希望的治疗途径.
- 对PAR2调节器的进一步研究可能会导致新的皮肤病治疗方法.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
T Cell Types and Functions
960
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
960
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


